LLY compared with VRDN: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

VRDNViridian Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

VRDN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±16.7%▲+15.53%×0.93

Q2 FY26±17.2%▲+6.83%×0.40

= impliedLLY realized, solidVRDN realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

May 5 '26

±9.5%

▲+33.36%

×3.52

Q1 FY26±24.8%▲+1.90%×0.08

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

VRDNViridian Therapeutics, Inc.

28.49▼−0.23%· post 28.97

ClosedNov 6 '26

Mkt cap$3.2BRevenue$26MQ3 FY26Revenue$71MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

VRDNViridian Therapeutics, Inc.

1,360.90▼−0.28%post 1,358.90

Price

28.49▼−0.23%post 28.97

$1.2T

Mkt cap

$3.2B

Q3 FY26$24.4B

Revenue

$26MQ3 FY26

FY25$65.2B

Revenue

$71MFY25

LLY1,360.90▼−0.28%vsVRDN28.49▼−0.23%ClosedNov 6 '26